Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments (original) (raw)
Delgado PL . Depression: the case for a monoamine deficiency J Clin Psychiatry 2000 61 (Suppl 6): 7–11 Google Scholar
Hirschfeld RM . History and evolution of the monoamine hypothesis of depression J Clin Psychiatry 2000 61 (Suppl 6): 4–6 Google Scholar
Berman RM, Krystal JH, Charney DS . Mechanism of action of antidepressants: monoamine hypotheses and beyond In: Watson SJ (ed) Biology of Schizophrenia and Affective Disease American Psychiatric Press: Washington, DC 1996 pp 295–368 Google Scholar
Duman RS, Malberg J, Thome J . Neural plasticity to stress and antidepressant treatment Biol Psychiatry 1999 46: 1181–1191 ArticleCASPubMed Google Scholar
Ikonomov OC, Manji HK . Molecular mechanisms underlying mood stabilization in manic-depressive illness: the phenotype challenge Am J Psychiatry 1999 156: 1506–1514 ArticleCASPubMed Google Scholar
Skolnick P, Layer RT, Popik P, Nowak G, Paul IA, Trullas R . Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression Pharmacopsychiatry 1996 29: 23–26 ArticleCASPubMed Google Scholar
Sanacora G, Mason GF, Krystal JH . Impairment of GABAergic transmission in depression: new insights from neuroimaging studies Crit Rev Neurobiol 2000 14: 23–45 ArticleCASPubMed Google Scholar
Drevets WC, Videen TO, Price JL, Preskorn SH, Carmichael ST, Raichle ME . A functional anatomical study of unipolar depression J Neurosci 1992 12: 3628–3641 ArticleCASPubMedPubMed Central Google Scholar
Sheline YI, Wang PW, Gado MH, Csernansky JG, Vannier MW . Hippocampal atrophy in recurrent major depression Proc Natl Acad Sci U S A 1996 93: 3908–3913 ArticleCASPubMedPubMed Central Google Scholar
Bremner JD, Narayan M, Anderson ER, Staib LH, Miller HL, Charney DS . Hippocampal volume reduction in major depression Am J Psychiatry 2000 157: 115–118 ArticleCASPubMed Google Scholar
Steffens DC, Byrum CE, McQuoid DR et al. Hippocampal volume in geriatric depression Biol Psychiatry 2000 48: 301–309 ArticleCASPubMed Google Scholar
Robinson RG, Chemerinski E, Jorge R . Pathophysiology of secondary depressions in the elderly J Geriatr Psychiatry Neurol 1999 12: 128–136 ArticleCASPubMed Google Scholar
Drevets WC, Price JL, Simpson JR Jr et al. Subgenual prefrontal cortex abnormalities in mood disorders Nature 1997 386: 824–827 ArticleCASPubMed Google Scholar
Ongur D, Drevets WC, Price JL . Glial reduction in the subgenual prefrontal cortex in mood disorders Proc Nalt Acad Sci U S A 1998 95: 13290–13295 ArticleCAS Google Scholar
Rajkowska G, Miguel-Hidalgo JJ, Wei J et al. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression Biol Psychiatry 1999 45: 1085–1098 ArticleCASPubMed Google Scholar
Malandro MS, Kilberg MS . Molecular biology of mammalian amino acid transporters Ann Rev Biochem 1996 65: 305–336 ArticleCASPubMed Google Scholar
Magistretti PJ, Pellerin L, Rothman DL, Shulman RG . Energy on demand Science 1999 283: 496–497 ArticleCASPubMed Google Scholar
During MJ, Spencer DD . Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain Lancet 1993 341: 1607–1610 ArticleCASPubMed Google Scholar
Drevets WC . Prefrontal cortical-amygdalar metabolism in major depression Ann N Y Acad Sci 1999 877: 614–637 ArticleCASPubMed Google Scholar
Mayberg HS, Liotti M, Brannan SK et al. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness Am J Psychiatry 1999 156: 675–682 CASPubMed Google Scholar
Blumberg HP, Stern E, Martinez D et al. Increased anterior cingulate and caudate activity in bipolar mania Biol Psychiatry 2000 48: 1045–1052 ArticleCASPubMed Google Scholar
Schell MJ, Brady RO Jr, Molliver ME, Snyder SH . D-serine as a neuromodulator: regional and developmental localizations in rat brain glia resemble NMDA receptors J Neurosci 1997 17: 1604–1615 ArticleCASPubMedPubMed Central Google Scholar
Sapolsky RM . Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders Arch Gen Psychiatry 2000 57: 925–935 ArticleCASPubMed Google Scholar
Cappiello A, Charney DS, Berman R et al. NMDA receptor function in major depression Biol Psychiatry 1997 41: 45S Google Scholar
Nowak G, Ordway GA, Paul IA . Alterations in the N-methyl-D-aspartate (NMDA) receptor complex in the frontal cortex of suicide victims Brain Res 1995 675: 157–164 ArticleCASPubMed Google Scholar
Mason GF, Sanacora G, Anand A et al. Cortical GABA reduced in unipolar, but not bipolar depression Biol Psychiatry 2000 47: 92S Google Scholar
Mason GF, Gruetter R, Rothman DL, Behar KL, Shulman RG, Novotny EJ . Simultaneous determination of the rates of the TCA cycle, glucose utilization, alpha-ketoglutarate/glutamate exchange, and glutamine synthesis in human brain by NMR J Cereb Blood Flow Metab 1995 15: 12–25 ArticleCASPubMed Google Scholar
Shen J, Petersen KF, Behar KL et al. Determination of the rate of the glutamate/glutamine cycle in the human brain by in vivo 13C NMR Proc Nat Acad Sci U S A 1999 96: 8235–8240 ArticleCAS Google Scholar
Mason GF, Haga K, Appel M et al. Measuring cortical GABA levels and neurotransmitter turnover with 1H-MRS and 13C-MRS Biol Psychiatry 2001 49: 148S Google Scholar
Auer DP, Putz B, Kraft E, Lipinski B, Schill J, Holsboer F . Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study Biol Psychiatry 2000 47: 305–313 ArticleCASPubMed Google Scholar
Papp M, Moryl E . New evidence for the antidepressant activity of MK-801, a non-competitive antagonist of NMDA receptors Pol J Pharmacol 1993 45: 549–553 CASPubMed Google Scholar
Wedzony K, Klimek V, Nowak G . Rapid down-regulation of beta-adrenergic receptors evoked by combined forced swimming test and CGP 37849—a competitive antagonist of NMDA receptors Pol J Pharmacol 1995 47: 537–540 CASPubMed Google Scholar
Wedzony K, Mackowiak M, Czyrak A, Fijal K, Michalska B . Single doses of MK-801, a non-competitive antagonist of NMDA receptors, increase the number of 5-HT1A serotonin receptors in the rat brain Brain Res 1997 756: 84–91 ArticleCASPubMed Google Scholar
Pallotta M, Segieth J, Whitton PS . N-methyl-D-aspartate receptors regulate 5-HT release in the raphe nuclei and frontal cortex of freely moving rats: differential role of 5-HT1A autoreceptors Brain Res 1998 783: 173–178 ArticleCASPubMed Google Scholar
Lejeune F, Gobert A, Rivet JM, Millan MJ . Blockade of transmission at NMDA receptors facilitates the electrical and synthetic activity of ascending serotoninergic neurones Brain Res 1994 656: 427–431 ArticleCASPubMed Google Scholar
Martin P, Carlsson ML, Hjorth S . Systemic PCP treatment elevates brain extracellular 5-HT: a microdialysis study in awake rats Neuroreport 1998 9: 2985–2988 ArticleCASPubMed Google Scholar
Nowak G, Redmond A, McNamara M, Paul IA . Swim stress increases the potency of glycine at the N-methyl-D-aspartate receptor complex J Neurochem 1995 64: 925–927 ArticleCASPubMed Google Scholar
Fitzgerald LW, Ortiz J, Hamedani AG, Nestler EJ . Drugs of abuse and stress increase the expression of GluR1 and NMDAR1 glutamate receptor subunits in the rat ventral tegmental area: common adaptations among cross-sensitizing agents J Neurosci 1996 16: 274–282 ArticleCASPubMedPubMed Central Google Scholar
Paul IA, Nowak G, Layer RT, Popik P, Skolnick P . Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments J Pharmacol Exp Ther 1994 269: 95–102 CASPubMed Google Scholar
Reynolds IJ, Miller RJ . Tricyclic antidepressants block N-methyl-D-aspartate receptors: similarities to the action of zinc Br J Pharmacol 1988 95: 95–102 ArticleCASPubMedPubMed Central Google Scholar
White G, Lovinger DM, Peoples RW, Weight FF . Inhibition of N-methyl-D-aspartate activated ion current by desmethylimipramine Brain Res 1990 537: 337–339 ArticleCASPubMed Google Scholar
Crane GE . The psychotropic effect of cycloserine: a new use of an antibiotic Compr Psychiatry 1961 2: 51–59 Article Google Scholar
Monahan JB, Corpus VM, Hood WF, Thomas JW, Compton RP . Characterization of a [3H]glycine recognition site as a modulatory site of the N-methyl-D-aspartate receptor complex J Neurochem 1989 53: 370–375 ArticleCASPubMed Google Scholar
Emmett MR, Mick SJ, Cler JA, Rao TS, Iyengar S, Wood PL . Actions of D-cycloserine at the N-methyl-D-aspartate-associated glycine receptor site in vivo Neuropharmacology 1991 30: 1167–1171 ArticleCASPubMed Google Scholar
Henderson G, Johnson JW, Ascher P . Competitive antagonists and partial agonists at the glycine modulatory site of the mouse N-methyl-D-aspartate receptor J Physiol 1990 430: 189–212 ArticleCASPubMedPubMed Central Google Scholar
Priestley T, Kemp JA . Kinetic study of the interactions between the glutamate and glycine recognition sites on the N-methyl-D-aspartic acid receptor complex Mol Pharmacol 1994 46: 1191–1196 CASPubMed Google Scholar
Krystal JH, Petrakis IL, D'Souza DC, Trevisan L, Krasnicki S, Charney DS . Interactive effects of high dose intravenous glycine and oral D-cycloserine in healthy human subjects Biol Psychiatry 1997 41 (Suppl): 23S Google Scholar
Krystal JH, Karper LP, Seibyl JP et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses Arch Gen Psychiatry 1994 51: 199–214 ArticleCASPubMed Google Scholar
Huber TJ, Dietrich DE, Emrich HM . Possible use of amantadine in depression Pharmacopsychiatry 1999 32: 47–55 ArticleCASPubMed Google Scholar
Danysz W, Parsons CG, Kornhuber J, Schmidt WJ, Quack G . Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents—preclinical studies Neurosci Biobehav Rev 1997 21: 455–468 ArticleCASPubMed Google Scholar
Kornhuber J, Quack G, Danysz W et al. Therapeutic brain concentration of the NMDA receptor antagonist amantadine Neuropharmacology 1995 34: 713–721 ArticleCASPubMed Google Scholar
Parsons CG, Panchenko VA, Pinchenko VO, Tsyndrenko AY, Krishtal OA . Comparative patch-clamp studies with freshly dissociated rat hippocampal and striatal neurons on the NMDA receptor antagonistic effects of amantadine and memantine Eur J Neurosci 1996 8: 446–454 ArticleCASPubMed Google Scholar
Bode L, Dietrich DE, Stoyloff R, Emrich HM, Ludwig H . Amantadine and human Borna disease virus in vitro and in vivo in an infected patients with bipolar depression Lancet 1997 349: 958 Article Google Scholar
Parkes JD, Zilkha KJ, Marsden P, Baxter RC, Knill-Jones RP . Amantadine dosage in treatment of Parkinson's disease Lancet 1970 1: 1130–1133 ArticleCASPubMed Google Scholar
Gortelmeyer R, Erbler H . Memantine in the treatment of mild to moderate dementia syndrome. A double-blind placebo-controlled study Arzneimittel-Forschung 1992 42: 904–913 CASPubMed Google Scholar
Ambrozi L, Danielczyk W . Treatment of impaired cerebral function in psychogeriatric patients with memantine—results of a phase II double-blind study Pharmacopsychiatry 1988 21: 144–146 ArticleCASPubMed Google Scholar
Berman RM, Cappiello A, Anand A, Oren D, Charney DS, Krystal JH . Antidepressant effects of ketamine in depressed patients Biol Psychiatry 2000 47: 351–354 ArticleCASPubMed Google Scholar
Blumberg HP, Leung HC, Wexler B et al. Ventral prefrontal dysfunction in bipolar disorder: an fMRI study Biol Psychiatry 2001 49: 26S Google Scholar
Starkstein SE, Robinson RG . Mechanism of disinhibition after brain lesions J Nerv Ment Dis 1997 185: 108–114 ArticleCASPubMed Google Scholar
Knight RT, Staines WR, Swick D, Chao LL . Prefrontal cortex regulates inhibition and excitation in distributed neural networks Acta Psychologica 1999 101: 159–178 ArticleCASPubMed Google Scholar
Blumberg HP, Stern E, Ricketts S et al. Rostral and orbital prefrontal cortex dysfunction in the manic state of bipolar disorder Am J Psychiatry 1999 156: 1986–1988 CASPubMed Google Scholar
Dixon JF, Hokin LE . Lithium acutely inhibits and chronically up-regulates and stabilizes glutamate uptake by presynaptic nerve endings in mouse cerebral cortex Proc Natl Acad Sci U S A 1998 95: 8363–8368 ArticleCASPubMedPubMed Central Google Scholar
Nonaka S, Hough CJ, Chuang DM . Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-D-aspartate receptor-mediated calcium influx Proc Natl Acad Sci U S A 1998 95: 2642–2647 ArticleCASPubMedPubMed Central Google Scholar
Manji HK, Lenox RH . Ziskind–Somerfeld Research Award. Protein kinase C signaling in the brain: molecular transduction of mood stabilization in the treatment of manic-depressive illness Biol Psychiatry 1999 46: 1328–1351 ArticleCASPubMed Google Scholar
Meldrum BS . The role of glutamate in epilepsy and other CNS disorders Neurology 1994 44 (Suppl 8): S14–23 Google Scholar
Cunningham MO, Jones RS . The anticonvulsant, lamotrigine decreases spontaneous glutamate release but increases spontaneous GABA release in the rat entorhinal cortex in vitro Neuropharmacology 2000 39: 2139–2146 ArticleCASPubMed Google Scholar
Lingamaneni R, Hemmings HC Jr . Effects of anticonvulsants on veratridine- and KCl-evoked glutamate release from rat cortical synaptosomes Neurosci Lett 1999 276: 127–130 ArticleCASPubMed Google Scholar
Calabresi P, Centonze D, Marfia GA, Pisani A, Bernardi G . An in vitro electrophysiological study on the effects of phenytoin, lamotrigine and gabapentin on striatal neurons Br J Pharmacol 1999 126: 689–696 ArticleCASPubMedPubMed Central Google Scholar
Waldmeier PC, Martin P, Stocklin K, Portet C, Schmutz M . Effect of carbamazepine, oxcarbazepine and lamotrigine on the increase in extracellular glutamate elicited by veratridine in rat cortex and striatum Naunyn-Schmiedebergs Arch Pharmacol 1996 354: 164–172 ArticleCASPubMed Google Scholar
Waldmeier PC, Baumann PA, Wicki P, Feldtrauer JJ, Stierlin C, Schmutz M . Similar potency of carbamazepine, oxcarbazepine, and lamotrigine in inhibiting the release of glutamate and other neurotransmitters Neurology 1995 45: 1907–1913 ArticleCASPubMed Google Scholar
Manji HK, Bebchuk JM, Moore GJ, Glitz D, Hasanat KA, Chen G . Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications J Clin Psychiatry 1999 60 (Suppl 2): 27–39 discussion 40–41 113–116 Google Scholar
Jakab RL, Goldman-Rakic PS . 5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites Proc Natl Acad Sci U S A 1998 95: 735–740 ArticleCASPubMedPubMed Central Google Scholar
Aghajanian GK, Marek GJ . Serotonin model of schizophrenia: emerging role of glutamate mechanisms Brain Res Brain Res Rev 2000 31: 302–312 ArticleCASPubMed Google Scholar
Scruggs JL, Patel S, Bubser M, Deutch AY . DOI-induced activation of the cortex: dependence on 5-HT2A heteroceptors on thalamocortical glutamatergic neurons J Neurosci (Online) 2000 20: 8846–8852 ArticleCAS Google Scholar
Marek GJ, Wright RA, Schoepp DD, Monn JA, Aghajanian GK . Physiological antagonism between 5-hydroxytryptamine(2A) and group II metabotropic glutamate receptors in prefrontal cortex J Pharmacol Exp Ther 2000 292: 76–87 CASPubMed Google Scholar
Marek GJ, McDougle CJ, Price LH, Seiden LS . A comparison of trazodone and fluoxetine: implications for a serotonergic mechanism of antidepressant action Psychopharmacology 1992 109: 2–11 ArticleCASPubMed Google Scholar
Guille C, Sachs GS, Ghaemi SN . A naturalistic comparison of clozapine, risperidone, and olanzapine in the treatment of bipolar disorder J Clin Psychiatry 2000 61: 638–642 ArticleCASPubMed Google Scholar
Keck PE Jr, McElroy SL, Strakowski SM, Soutullo CA . Antipsychotics in the treatment of mood disorders and risk of tardive dyskinesia J Clin Psychiatry 2000 61 (Suppl 4): 33–38 Google Scholar
Moghaddam B, Adams B, Verma A, Daly D . Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex J Neurosci 1997 17: 2921–2927 ArticleCASPubMedPubMed Central Google Scholar
Moghaddam B, Adams BW . Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats Science 1998 281: 1349–1352 ArticleCASPubMed Google Scholar
Luby ED, Cohen BD, Rosenbaum G, Gottlieb JS, Kelley R . Study of a new schizophrenomimetic drug—sernyl Arch Neurol Psychiatry 1959 81: 363–369 ArticleCAS Google Scholar
Breier A, Malhotra AK, Pinals DA, Weisenfeld NI, Pickar D . Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers Am J Psychiatry 1997 154: 805–811 ArticleCASPubMed Google Scholar
Lahti AC, Holcomb HH, Medoff DR, Tamminga CA . Ketamine activates psychosis and alters limbic blood flow in schizophrenia Neuroreport 1995 6: 869–872 ArticleCASPubMed Google Scholar
Vollenweider FX, Leenders KL, Oye I, Hell D, Angst J . Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET) Eur Neuropsychopharmacol 1997 7: 25–38 ArticleCASPubMed Google Scholar
Krystal JH, Belger A, Kirino E, Gore J, McCarthy G . Ketamine effects on the cortical processing of novelty in humans assessed with fMRI Soc Neurosci Abstr 1998 24: 104.7 Google Scholar
Anand A, Charney DS, Cappiello A, Berman RM, Oren DA, Krystal JH . Lamotrigine attenuates ketamine effects in humans: support for hyperglutamatergic effects of NMDA antagonists Arch Gen Psychiatry 2000 57: 270–276 ArticleCASPubMed Google Scholar
Krupitsky EM, Burakov AM, Romanova TN et al. Attenuation of ketamine effects by nimodipine in recently detoxified ethanol dependent men: psychopharmacologic implications of the interaction of NMDA and L-type calcium channel antagonists Neuropsychopharmacology 2001 25: 936–947 ArticleCASPubMed Google Scholar
Calabrese JR, Bowden CL, Sachs GS, Ascher JA, Monaghan E, Rudd GD . A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group J Clin Psychiatry 1999 60: 79–88 ArticleCASPubMed Google Scholar
Newcomer JW, Farber NB, Selke G, Melson AK, Jevtovic-Todorovic V, Olney JW . Guanabenz effects on NMDA antagonist-induced mental symptoms in human Soc Neurosci Abstr 1998 24: 211.2 Google Scholar
Giannini AJ, Pascarzi GA, Loiselle RH, Price WA, Giannini MC . Comparison of clonidine and lithium in the treatment of mania Am J Psychiatry 1986 143: 1608–1609 ArticleCASPubMed Google Scholar
Zubenko GS, Cohen BM, Lipinski JF Jr, Jonas JM . Clonidine in the treatment of mania and mixed bipolar disorder Am J Psychiatry 1984 141: 1617–1618 ArticleCASPubMed Google Scholar
Lahti AC, Weiler MA, Parwani A et al. Blockade of ketamine-induced psychosis with olanzepine Schizophr Res 1999 36: 310 Google Scholar
Vollenweider FX, Bachle D, Umbricht D, Geyer M, Hell D . Sertindole reduces S-ketamine induced attentional deficits in healthy volunteers Biol Psychiatry 1999 100S
Krystal JH, Karper LP, Bennett A et al. Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans Psychopharmacology 1998 135: 213–229 ArticleCASPubMed Google Scholar
Bovill JG, Clarke RSJ, Dundee JW, Pandit SK, Moore J . Effect of premedicants and supplements on ketamine anesthesia Br J Anaesth 1971 43: 600–608 ArticleCASPubMed Google Scholar
Bradwejn J, Shriqui C, Koszycki D, Meterissian G . Double-blind comparison of the effects of clonazepam and lorazepam in acute mania J Clin Psychopharmacol 1990 10: 403–408 ArticleCASPubMed Google Scholar
Lenox RH, Newhouse PA, Creelman WL, Whitaker TM . Adjunctive treatment of manic agitation with lorazepam versus haloperidol: a double-blind study J Clin Psychiatry 1992 53: 47–52 CASPubMed Google Scholar
Petty F . GABA and mood disorders: a brief review and hypothesis J Affect Disord 1995 34: 275–281 ArticleCASPubMed Google Scholar
Roy A, DeJong J, Lamparski D, George T, Linnoila M . Depression among alcoholics. Relationship to clinical and cerebrospinal fluid variables Arch Gen Psychiatry 1991 48: 428–432 ArticleCASPubMed Google Scholar
Rutherford LC, DeWan A, Lauer HM, Turrigiano GG . Brain-derived neurotrophic factor mediates the activity-dependent regulation of inhibition in neocortical cultures J Neurosci 1997 17: 4527–4535 ArticleCASPubMedPubMed Central Google Scholar
Vaidya VA, Terwilliger RM, Duman RS . Role of 5-HT2A receptors in the stress-induced down-regulation of brain-derived neurotrophic factor expression in rat hippocampus Neurosci Lett 1999 262: 1–4 ArticleCASPubMed Google Scholar
Chen RW, Chuang DM . Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity J Biol Chem 1999 274: 6039–6042 ArticleCASPubMed Google Scholar
Mora A, Gonzalez-Polo RA, Fuentes JM, Soler G, Centeno F . Different mechanisms of protection against apoptosis by valproate and Li+ Eur J Biochem 1999 266: 886–891 ArticleCASPubMed Google Scholar
Rothman DL, Petroff OA, Behar KL, Mattson RH . Localized 1H NMR measurements of gamma-aminobutyric acid in human brain in vivo Proc Natl Acad Sci U S A 1993 90: 5662–5666 ArticleCASPubMedPubMed Central Google Scholar
Petroff OA, Rothman DL . Measuring human brain GABA in vivo: effects of GABA-transaminase inhibition with vigabatrin Mol Neurobiol 1998 16: 97–121 ArticleCASPubMed Google Scholar
Sanacora G, Mason GF, Rothman DL et al. Reduced cortical GABA levels in depressed patients determined by 1H-magnetic resonance spectroscopy Arch Gen Psychiatry 1999 56: 1043–1047 ArticleCASPubMed Google Scholar
Goddard AW, Mason GF, Rothman DL et al. Reduction in cortical GABA levels in panic disorder assessed using [1H] magneticresonance spectroscopy Arch Gen Psychiatry 2001 58: 556–561 ArticleCASPubMed Google Scholar
Foley DL, Neale MC, Kendler KS . Reliability of a lifetime history of major depression: implications for heritability and co-morbidity Psychol Med 1998 28: 857–870 ArticleCASPubMed Google Scholar
Weissman MM, Wickramaratne P, Adams PB et al. The relationship between panic disorder and major depression. A new family study Arch Gen Psychiatry 1993 50: 767–780 ArticleCASPubMed Google Scholar
Monteleone P, Luisi S, Tonetti A et al. Allopregnanolone concentrations and premenstrual syndrome Eur J Endocrinol 2000 142: 269–273 ArticleCASPubMed Google Scholar
Bicikova M, Dibbelt L, Hill M, Hampl R, Starka L . Allopregnanolone in women with premenstrual syndrome Horm Metab Res 1998 30: 227–230 ArticleCASPubMed Google Scholar
Rapkin AJ, Morgan M, Goldman L, Brann DW, Simone D, Mahesh VB . Progesterone metabolite allopregnanolone in women with premenstrual syndrome Obstet Gynecol 1997 90: 709–714 ArticleCASPubMed Google Scholar
Schmidt PJ, Purdy RH, Moore PH Jr, Paul SM, Rubinow DR . Circulating levels of anxiolytic steroids in the luteal phase in women with premenstrual syndrome and in control subjects J Clin Endocrinol Metab 1994 79: 1256–1260 CASPubMed Google Scholar
Petty F, Sherman AD . GABAergic modulation of learned helplessness Pharmacol Biochem Behav 1981 15: 567–570 ArticleCASPubMed Google Scholar
Lloyd KG, Zivkovic B, Scatton B, Morselli PL, Bartholini G . The gabaergic hypothesis of depression Prog Neuropsychopharmacol Biol Psychiatry 1989 13: 341–351 ArticleCASPubMed Google Scholar
Sackeim HA, Decina P, Prohovnik I, Malitz S, Resor SR . Anticonvulsant and antidepressant properties of electroconvulsive therapy: a proposed mechanism of action Biol Psychiatry 1983 18: 1301–1310 CASPubMed Google Scholar
Grahame-Smith DG . The neuropharmacological effects of electroconvulsive shock and their relationship to the therapeutic effect of electroconvulsive therapy in depression Adv Biochem Psychopharmacol 1984 39: 327–343 CASPubMed Google Scholar
Green AR, Vincent ND . The effect of repeated electroconvulsive shock on GABA synthesis and release in regions of rat brain Br J Pharmacol 1987 92: 19–24 ArticleCASPubMedPubMed Central Google Scholar
Sanacora G, Mason GF, Rothman DL, Berman RM, Charney DS, Krystal JH . ECT effects on cortical GABA levels as determined by 1H-MRS. Scientific Abstracts from the 37th Annual Meeting of the American College of Neuropsychopahrmacology, Las Croabas, Puerto Rico 1998 p 200
Sanacora G, Mason GF, Rothman DL, Berman RM, Zimolo Z, Krystal JH . Cortical GABA concentrations are increased in depressed patients following treatment with selective serotonin reuptake inhibitors. Scientific Abstracts from the 39th Annual Meeting of the American College of Neuropsychopharmacology, San Juan, PR 2000 p 200
Petroff OA, Rothman DL, Behar KL, Mattson RH . Low brain GABA level is associated with poor seizure control Ann Neurol 1996 40: 908–911 ArticleCASPubMed Google Scholar
Petroff OA, Rothman DL, Behar KL, Collins TL, Mattson RH . Human brain GABA levels rise rapidly after initiation of vigabatrin therapy Neurology 1996 47: 1567–1571 ArticleCASPubMed Google Scholar
Petroff OA, Rothman DL, Behar KL, Lamoureux D, Mattson RH . The effect of gabapentin on brain gamma-aminobutyric acid in patients with epilepsy Ann Neurol 1996 39: 95–99 ArticleCASPubMed Google Scholar
Petroff OA, Hyder F, Mattson RH, Rothman DL . Topiramate increases brain GABA, homocarnosine, and pyrrolidinone in patients with epilepsy Neurology 1999 52: 473–478 ArticleCASPubMed Google Scholar